中医药在动脉硬化性疾病防治研究中的比较优势及思考
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金重大研究计划(9079008、90209001)


Advantages of Traditional Chinese Medicine on Prevention and Treatment of the Atherosclerosis-related Diseases
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    动脉粥样硬化性疾病属于复杂性慢性疾病。其发病机理尚不很清楚。目前国内临床所用西药均由国外创制。中医药科技工作者发挥祖国医学的独特优势,在中医基础理论指导下,从临床实践到药物研发。经过不断摸索,取得了一批重大成果,为动脉硬化性疾病的防治创制出了一批疗效确切,业界认可,并开始走向世界的创制新药。本文扼要介绍了其中最具代表性的重大成果。

    Abstract:

    Atherosclerosis-related diseases is a complex chronic disease.The exact pathogenesis of the disease is still unclear.So far, chemical drugs used to treat the disease in China are all developed outside China.The scientists worked in Traditional Chinese Medicine take its unique advantages.Under the guidance of TCM basic theory, trial and e-rror, a number of significant achievements have been acquired through clinical practice and drug discovery and development.New drugs which have determined curative effect was created for the prevention and treatment of atherosclerotic disease.They have been recognized and accepted on field of medicine, then go to the world.This article provides an overview of the most representative achievements.

    参考文献
    相似文献
    引证文献
引用本文

宋剑南.中医药在动脉硬化性疾病防治研究中的比较优势及思考[J].中国动脉硬化杂志,2012,20(3):193~196.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2011-10-27
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: